{"url_path":"/sec/pets/10-k/2026/item-10","section_key":"item-10","section_title":"Item 10 DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1040130/0001040130-26-000019-index.html","accession_number":"0001040130-26-000019","cik":"0001040130","ticker":"PETS","issuer_name":"PETMED EXPRESS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1040130/0001040130-26-000019-index.html","primary_entity_key":"0001040130","primary_entity_name":"PETMED EXPRESS INC"},"word_count":203,"has_tables":true,"body_markdown":"ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE\n\nThe information required by this item will be set forth in our proxy statement, to be filed with the SEC within 120 days after the end of the fiscal year ended March 31, 2026, relating to our 2026 Annual Meeting of Shareholders and is incorporated herein by reference.\n\nCode of Business Conduct and Ethics\n\nWe have a Corporate Code of Business Conduct and Ethics (\"Code\") applicable to all officers, directors, and employees. The Code is available on our website at www.petmeds.com under “Investors - Governance”. You may also obtain a copy of our Code free of charge by contacting Investor Relations at 1-800-738-6337. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendment to, or waiver from, a provision of this Code by posting such information on the website address and location specified above.\n\nInsider Trading Policy\n\nThe Company has adopted an Insider Trading Policy governing the purchase, sale, and/or other dispositions of the Company’s securities that is reasonably designed to promote compliance with applicable laws, rules and regulations. A copy of the Company’s Insider Trading Policy has been filed as Exhibit 19.1 to this Annual Report on Form 10-K."}